ASUR
- NASDAQ - Computer Sftwr-Enterprse
Asure Software Inc
|
$7.63 |
+0.18
2.42%
|
$8.00
|
$8.00
|
-4.63% |
63,702 255.83%
|
24,900
|
Most Recent Note for ASUR - 7/13/2012 12:09:32 PM
Hitting another new 52-week high with today's gain, adding to a recent spurt of volume-driven gains. Found support at its 200 DMA line during its consolidation since noted in the 2/15/12 mid-day report - "Sales and earnings history is not a match with the fact-based system's guidelines. Low-priced stocks are not considerable under the fact-based system unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BKR
- NYSE - Oil&Gas-Machinery/Equip
Baker Hughes Co Cl A
|
$25.04 |
-0.08 -0.32%
|
$25.58
|
$27.43
|
-8.71% |
20,753 62.70%
|
33,100
|
Most Recent Note for BKR - 7/13/2012 12:11:32 PM
The 7/05/12 mid-day report noted - "Small supply of shares outstanding (the S criteria) may contribute to greater price volatility. Its quarterly and annual earnings history (C and A criteria) has not been a match with the investment system's fundamental requirements."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BTN
- AMEX - CONSUMER DURABLES - Photographic Equipment & Suppl
Ballantyne Strong Inc
|
$5.60 |
+0.09
1.63%
|
$5.61
|
$6.48
|
-13.58% |
68,546 68.07%
|
100,700
|
Most Recent Note for BTN - 7/13/2012 12:13:01 PM
Slumped below its 50 DMA line and sputtered since last noted in the 5/24/12 mid-day report - "Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Quarterly and annual earnings history has been erratic and not a match with the fact-based investment system's guidelines. Consensus estimates are calling for its FY '12 earnings to drop -15%, adding another fundamental concern."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BYI
- NYSE - Leisure-Gaming/Equip
Bally Technologies Inc
|
$46.06 |
+0.88
1.95%
|
$46.34
|
$49.32
|
-6.61% |
276,916 59.63%
|
464,400
|
Most Recent Note for BYI - 7/13/2012 12:15:08 PM
Perched -6.5% off its 52-week high today and slumping under its 50 DMA line, building on a 12-week base. Recent quarterly comparisons through Mar '12 showed encouraging sales revenues and earnings acceleration. Prior mid-day reports noted - "Quarterly and annual earnings history has been below the guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CACC
- NASDAQ - FINANCIAL SERVICES - Credit Services
Credit Acceptance Corp
|
$93.88 |
+1.72
1.87%
|
$93.94
|
$107.09
|
-12.34% |
22,131 58.09%
|
38,100
|
Most Recent Note for CACC - 7/13/2012 12:19:25 PM
Reported earnings +11% on +15% sales revenues for the quarter ended March 31, 2012 versus the year ago period, below the investment system's guidelines, continuing the previously noted deceleration. Found support near its 200 DMA line while consolidating since last noted in the 3/28/12 mid-day report - "Quarterly and annual earnings history has been strong and satisfies the C & A criteria, however the 3 recent quarters' earnings increases, sequentially, decelerated to the minimum +25% level in the Dec '11 comparison. Rebounded from a deep consolidation below its 200 DMA line since noted 8/05/11 - 'Based on weak action it will be dropped from the Featured Stocks list tonight.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DGX
- NYSE - HEALTH SERVICES - Medical Laboratories & Researc
Quest Diagnostics Inc
|
$62.95 |
-0.14 -0.22%
|
$63.04
|
$63.98
|
-1.61% |
755,605 68.37%
|
1,105,100
|
Most Recent Note for DGX - 7/13/2012 12:28:49 PM
Technically, it broke out to new 52-week and multi-year highs with a considerable volume-driven gain on the prior session. Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FDO
- NYSE - RETAIL - Discount, Variety Stores
Family Dollar Stores
|
$67.51 |
-1.14 -1.66%
|
$69.15
|
$74.73
|
-9.66% |
1,043,287 58.94%
|
1,770,200
|
Most Recent Note for FDO - 7/13/2012 12:29:50 PM
Losses this week have it slumping back below its 50 DMA line. Encountered distributional pressure after the 6/14/12 mid-day report noted - "Gapped up today for a considerable volume-driven gain to new 52-week and all-time highs. Held its ground above its 50 DMA line, an important support level, during its consolidation since last noted in the 4/18/12 mid-day report - 'The C criteria is not satisfied. Sales revenues and earnings growth history below guidelines.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IDXX
- NASDAQ - DRUGS - Diagnostic Substances
Idexx Laboratories Inc
|
$92.51 |
-1.13 -1.21%
|
$93.28
|
$98.38
|
-5.97% |
241,372 82.66%
|
292,000
|
Most Recent Note for IDXX - 7/13/2012 12:30:29 PM
Recently encountering some distributional pressure after volume-driven gains helped it rally to new all-time highs. No resistance remains due to overhead supply. Prior mid-day reports repeatedly noted - "Earnings history has been below the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MYE
- NYSE - Containers/Packaging
Myers Industries Inc
|
$17.04 |
+0.60
3.65%
|
$17.12
|
$17.98
|
-5.23% |
437,194 224.09%
|
195,100
|
Most Recent Note for MYE - 7/13/2012 12:32:54 PM
Volume-driven gain today helped it promptly rebound above its 50 DMA line after violating that important short-term average on the prior session. Perched within close striking distance of its 52-week high. Prior mid-day reports noted - "Recent quarterly comparisons show great earnings increases, but a lack of sales revenues growth and its sub par annual earnings (A criteria) history leave fundamental concerns."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$146.25 |
+0.21
0.14%
|
$146.43
|
$152.31
|
-3.98% |
499,608 112.96%
|
442,300
|
Most Recent Note for NVO - 7/13/2012 12:33:21 PM
Rebounded above its 50 DMA line in recent weeks and it is now perched -3.9% off its all-time high. Its 3 latest quarterly comparisons through Mar '12 had earnings increases below the +25% guideline (not meeting the C criteria). It went through a deep consolidation below its 200 DMA line then rebounded since noted in the 7/28/11 mid-day report. - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm also has seen the number of top-rated funds owning its shares rise from 152 in Mar '10 to 204 in Mar '11, a reassuring sign concerning the I criteria."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OABC
- NASDAQ - BANKING - Regional - Southwest Banks
Omniamerican Bancorp
|
$22.05 |
+0.44
2.04%
|
$22.07
|
$22.19
|
-0.63% |
30,254 66.06%
|
45,800
|
Most Recent Note for OABC - 7/13/2012 12:35:08 PM
Hitting a new 52-week high today with a 5th consecutive gain. Held its ground stubbornly and continued rising since in the 6/06/12 mid-day report - "Rebounded above its 50 DMA line with today's 3rd consecutive gain. No resistance remains due to overhead supply. Recent quarters showed better earnings versus the year earlier, however unimpressive sales revenues growth suggests no great demand for new (N criteria) products or services."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SNI
- NYSE - MEDIA - CATV Systems
Scripps Ntwrks Intr Cl A
|
$54.39 |
+1.51
2.86%
|
$54.88
|
$57.75
|
-5.82% |
769,821 66.12%
|
1,164,300
|
Most Recent Note for SNI - 7/13/2012 12:37:00 PM
Rebounding toward its 50 DMA line today after violating it during a streak of 7 consecutive losses with below average volume. Last noted in the 6/06/12 mid-day report - "Fundamentals are below guidelines of the investment system. Reported earnings +18% on +11% sales revenues for the quarter ended March 31, 2012 versus the year ago period."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SWHC
- NASDAQ - CONSUMER DURABLES - Sporting Goods
Smith & Wesson Hldg Corp
|
$9.60 |
+0.42
4.58%
|
$9.67
|
$9.66
|
-0.62% |
1,538,543 92.86%
|
1,656,800
|
Most Recent Note for SWHC - 7/13/2012 12:38:10 PM
Held its ground stubbornly following considerable volume-driven gains and today's gain helped it hit another new 52-week high. Prior mid-day reports noted - "Its earnings in the quarter ended April 30, 2012 showed a +125% increase on +26% sales revenues versus the year ago period. Its quarterly and annual earnings history has not been strong and steady since noted in the 10/30/07 mid-day report."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TITN
- NASDAQ - SPECIALTY RETAIL
Titan Machinery Inc
|
$31.73 |
+1.63
5.42%
|
$31.82
|
$36.92
|
-14.06% |
307,884 61.94%
|
497,100
|
Most Recent Note for TITN - 7/13/2012 12:41:11 PM
Rallying back above its 50 DMA line today. Found support at its 200 DMA line during a deep consolidation since last noted at its 52-week high in the 4/16/12 mid-day report - "Reported earnings +47% on +65% sales revenues for the quarter ended January 31, 2012 versus the year ago period. Technically, it broke out from a sound base pattern with a volume-driven gain on 4/09/12. It when through a deep consolidation below its 200 DMA line since completing a new Public Offering on 5/06/11. The 6 most recent quarterly comparisons show improving sales revenues and earnings increases, but its annual earnings history (A criteria) had a downward turn in FY '10, making it fall below the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TRIB
- NASDAQ - DRUGS - Diagnostic Substances
Trinity Biotech Plc Adr
|
$12.68 |
+0.22
1.73%
|
$12.72
|
$12.72
|
-0.35% |
50,274 98.19%
|
51,200
|
Most Recent Note for TRIB - 7/13/2012 12:42:01 PM
Trading up again today, rallying further into new 52-week high territory. Recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted - "Consolidating above prior highs and its 50 DMA line in the $11 area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (A criteria) showed steady increases since a downturn in FY '08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, 'How To Make Money In Stocks'. The past 8 quarterly earnings comparisons through Mar '12 were below the +25% minimum guideline of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VASC
- NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies
Vascular Solutions
|
$13.23 |
+0.17
1.29%
|
$13.30
|
$13.75
|
-3.80% |
31,607 64.77%
|
48,800
|
Most Recent Note for VASC - 7/13/2012 12:47:06 PM
Approaching its 52-week and multi-year highs. Fundamentals are still not a match with the fact-based investment system's guidelines. Survived but failed to impress since last noted in the 8/08/11 mid-day report - "Gapped down today, pulling back from its 52-week high hit last week. Annual earnings (A criteria) history has been good. The 2 latest quarterly comparisons versus the year ago period showed sales revenues increases in the +14-17% range with earnings per share increases in the +25-44% range. Ownership by top-rated funds fell from 124 in Dec '10 to 116 in Jun '11, whereas increasing institutional interest (I criteria) is clearly desired."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|